Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder

The activity of the presynaptic dopamine (DA) transporter (DAT) is critical in mediating the magnitude and duration of dopaminergic signaling in the brain. Multiple genetic studies have found an association between attention deficit hyperactivity disorder (ADHD) and a variable number tandem repeat (VNTR) in the 3'-untranslated region (3'VNTR) of the hDAT gene (SLC6A3), however none of these studies examined the hDAT coding region for polymorphisms. Thus, we sought evidence of polymorphisms in hDAT, focusing on the coding region and splice junctions, utilizing genomic DNA from children diagnosed with ADHD. Two separate ADHD cohorts (N=70 and N=42) were screened and sampled for both status of the 3'VNTR and for common/novel genomic variants. We found evidence of increased DAT variation in African-American subjects as well as in predominantely hyperactive-impulsive probands. Cumulatively, multiple hDAT sequence variants were identified, including five novel variants, as well as one nonsynonymous single nucleotide polymorphism (SNP), converting Ala559 to Val (A559V). A559V was identified in two Caucasian male siblings with ADHD and both subjects were homozygous for the ADHD-associated, 10-repeat 3'VNTR allele. Interestingly, the A559V variant was previously identified in a subject with bipolar disorder [. Molecular Psychiatry 5, 275], a psychiatric disorder that has a significant number of overlapping symptoms with ADHD.

[1]  M. Nöthen,et al.  Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder , 2001, Biological Psychiatry.

[2]  M. DelBello,et al.  DSM-IV mania symptoms in a prepubertal and early adolescent bipolar disorder phenotype compared to attention-deficit hyperactive and normal controls. , 2002, Journal of child and adolescent psychopharmacology.

[3]  Chan-Hyung Kim,et al.  Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[4]  M A Geyer,et al.  Prepulse Inhibition Deficits and Perseverative Motor Patterns in Dopamine Transporter Knock-Out Mice: Differential Effects of D1 and D2 Receptor Antagonists , 2001, The Journal of Neuroscience.

[5]  E H Cook,et al.  Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations , 2000, Molecular Psychiatry.

[6]  D. Weinberger,et al.  Genes, dopamine and cortical signal-to-noise ratio in schizophrenia , 2004, Trends in Neurosciences.

[7]  Jonathan C. Cohen,et al.  Multiple Rare Alleles Contribute to Low Plasma Levels of HDL Cholesterol , 2004, Science.

[8]  S. Purcell,et al.  The dopamine transporter gene is associated with attention deficit hyperactivity disorder in a Taiwanese sample , 2003, Molecular Psychiatry.

[9]  K. Chang,et al.  Characterization of children of bipolar parents by parent report CBCL. , 2002, Journal of psychiatric research.

[10]  R. Joober,et al.  Dopamine genes and attention-deficit hyperactivity disorder: a review. , 2003, Journal of psychiatry & neuroscience : JPN.

[11]  A. Heath,et al.  No association of the dopamine transporter gene 3' VNTR polymorphism with ADHD subtypes in a population sample of twins. , 2001, American journal of medical genetics.

[12]  Darin D Dougherty,et al.  Dopamine transporter density in patients with attention deficit hyperactivity disorder , 1999, The Lancet.

[13]  D. Mennin,et al.  Mania-like symptoms suggestive of childhood-onset bipolar disorder in clinically referred children. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.

[14]  J. Gelernter,et al.  Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), mu opioid receptor (OPRM1), and ciliary neurotrophic factor (CNTF)). , 1998, Genomics.

[15]  M. Gill,et al.  Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci , 2003, Molecular Psychiatry.

[16]  Donald C. Cooper,et al.  Loss of autoreceptor functions in mice lacking the dopamine transporter , 1999, Nature Neuroscience.

[17]  M. Gill,et al.  Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism , 1997, Molecular Psychiatry.

[18]  S. Cichon,et al.  Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1) , 2000, Molecular Psychiatry.

[19]  I. Waldman,et al.  Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. , 1998, American journal of human genetics.

[20]  T. Ketter,et al.  Psychiatric phenomenology of child and adolescent bipolar offspring. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

[21]  F. Bloom,et al.  The Biochemical Basis of Neuropharmacology , 1976 .

[22]  X Li,et al.  Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. , 1992, Genomics.

[23]  M. Gill,et al.  Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children , 1999, Molecular Psychiatry.

[24]  B. Greenberg,et al.  Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype , 2003, Molecular Psychiatry.

[25]  S. Strakowski,et al.  The comorbidity of attention-deficit hyperactivity disorder in adolescent mania: potential diagnostic and treatment implications. , 1995, Psychopharmacology bulletin.

[26]  Molecular genetics of Alzheimer’s disease , 2000, Biological Psychiatry.

[27]  D. Comings,et al.  Association of the dopamine transporter gene (DAT1) with poor methylphenidate response. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[28]  S. Fuke,et al.  The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression , 2001, The Pharmacogenomics Journal.

[29]  D. Mennin,et al.  Is comorbidity with ADHD a marker for juvenile-onset mania? , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[30]  D. Mennin,et al.  A pilot family study of childhood-onset mania. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.

[31]  N. Nelson,et al.  The Family of Na+/Cl− Neurotransmitter Transporters , 1998, Journal of neurochemistry.

[32]  Yu-Shin Ding,et al.  Therapeutic Doses of Oral Methylphenidate Significantly Increase Extracellular Dopamine in the Human Brain , 2001, The Journal of Neuroscience.

[33]  P. Ambrosini Historical development and present status of the schedule for affective disorders and schizophrenia for school-age children (K-SADS). , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

[34]  J. Swanson,et al.  High prevalence of rare dopamine receptor D4 alleles in children diagnosed with attention-deficit hyperactivity disorder , 2003, Molecular Psychiatry.

[35]  R. Gainetdinov,et al.  Genetics of childhood disorders: XXIV. ADHD, part 8: hyperdopaminergic mice as an animal model of ADHD. , 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

[36]  A. Thapar,et al.  Genetic basis of attention deficit and hyperactivity , 1999, British Journal of Psychiatry.

[37]  I. Craig,et al.  Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR. , 2002, American journal of medical genetics.

[38]  M. Caron,et al.  Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. , 1992, Molecular pharmacology.

[39]  E. Bowman,et al.  Evidence suggesting the role of specific genetic factors in cigarette smoking. , 1999, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[40]  M. Owen,et al.  A family-based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder , 2000, Molecular Psychiatry.

[41]  John P Seibyl,et al.  Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder. , 2002, The American journal of psychiatry.

[42]  P. Keck,et al.  Segmental linkage disequilibrium within the dopamine transporter gene , 2002, Molecular Psychiatry.

[43]  E D Levin,et al.  Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. , 1999, Science.

[44]  R. Mark Wightman,et al.  Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter , 1996, Nature.

[45]  W. Wetsel,et al.  Anterior Pituitary Hypoplasia and Dwarfism in Mice Lacking the Dopamine Transporter , 1997, Neuron.

[46]  K.,et al.  Psychiatric and Medical Comorbidities of Bipolar Disorder , 2005, Psychosomatic medicine.

[47]  B. Madras,et al.  Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression , 2002, Molecular Psychiatry.

[48]  George R. Uhl,et al.  D2 dopamine receptor Gene TaqI A1 and B1 restriction fragment length polymorphisms: Enhanced frequencies in psychostimulant-preferring polysubstance abusers , 1996, Biological Psychiatry.

[49]  S. Nelson,et al.  No evidence of linkage or linkage disequilibrium between DAT1 and attention deficit hyperactivity disorder in a large sample. , 1999, Psychiatric genetics.

[50]  A Second Generation Catecholamine Hypothesis , 1982 .

[51]  R. Rodriguiz,et al.  Aberrant responses in social interaction of dopamine transporter knockout mice , 2004, Behavioural Brain Research.

[52]  J. Gelernter,et al.  Genetic Association between Dopamine Transporter Protein Alleles and Cocaine-Induced Paranoia , 1994, Neuropsychopharmacology.

[53]  Zhaowei Liu,et al.  Integrated platform for detection of DNA sequence variants using capillary array electrophoresis , 2002, Electrophoresis.

[54]  A. Singleton,et al.  Genes and parkinsonism , 2003, The Lancet Neurology.

[55]  R. Blakely,et al.  Pharmacological profile of antidepressants and related compounds at human monoamine transporters. , 1997, European journal of pharmacology.

[56]  B. Giros,et al.  Behavioral Disturbances Associated with Hyperdopaminergia in Dopamine-transporter Knockout Mice , 2022 .

[57]  N J Cox,et al.  Association of attention-deficit disorder and the dopamine transporter gene. , 1995, American journal of human genetics.

[58]  K. Tatsch,et al.  Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment , 2000, European Journal of Nuclear Medicine.

[59]  I. Waldman,et al.  A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder. , 2003, Pediatrics.

[60]  C. Cusin,et al.  Dopamine transporter haplotype and attention-deficit hyperactivity disorder , 2005, Molecular Psychiatry.

[61]  Klaus Tatsch,et al.  Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography , 2000, Neuroscience Letters.

[62]  J. Mill,et al.  Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples , 2001, Molecular Psychiatry.

[63]  David J. States,et al.  QGB: Combined Use of Sequence Similarity and Codon Bias for Coding Region Identification , 1994, J. Comput. Biol..

[64]  R. Blakely,et al.  Expression studies of naturally occurring human dopamine transporter variants identifies a novel state of transporter inactivation associated with Val382Ala , 2005, Neuropharmacology.

[65]  M. Geyer,et al.  Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system , 2003, Biological Psychiatry.

[66]  D. Blakely,et al.  Population genetic study of the human dopamine transporter gene (DAT1) , 1995, Genetic epidemiology.

[67]  N. Ryan,et al.  Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[68]  E. Cook,et al.  Dopamine Transporter Genotype and Methylphenidate Dose Response in Children with ADHD , 2005, Neuropsychopharmacology.

[69]  D. Diehl,et al.  The role of dopamine in mood disorders. , 1992, Comprehensive psychiatry.

[70]  R. Post,et al.  A dopaminergic mechanism in mania. , 1976, The American journal of psychiatry.

[71]  A. Carlsson Perspectives on the discovery of central monoaminergic neurotransmission. , 1987, Annual review of neuroscience.